Cellectis (CLLS) FCF Payout Ratio (2015 - 2026)

Cellectis (CLLS) posted quarterly FCF Payout Ratio of 2.3 for Q1 2026, up 69.78% year-over-year from 1.35 in Q1 2025, and down 111.86% quarter-over-quarter from 19.4 in Q3 2025.

Cellectis (CLLS) FCF Payout Ratio (2015 - 2026) Analysis & Trends

Cellectis' FCF Payout Ratio history runs 12 years deep, the most recent figure standing at 2.3 for Q1 2026.

  • In Q1 2026, FCF Payout Ratio rose 69.78% year-over-year to 2.3; the TTM figure through Mar 2026 stood at 2.17 (down 120.23% YoY), while the FY2016 annual figure was 14.06, down 131.87% from the prior year.
  • FCF Payout Ratio for Q1 2026 stood at 2.3, down from 19.4 in the prior quarter.
  • The five-year high for FCF Payout Ratio was 19.4 in Q3 2025, with the low at 7.61 in Q1 2025.
  • The 5-year median for FCF Payout Ratio is 0.06 (2023), against an average of 0.43.
  • The sharpest annual moves came in 2024 and 2025: FCF Payout Ratio sank 295.94% in 2024, then jumped 1283.84% in 2025.
  • Cellectis' FCF Payout Ratio stood at 1.24 in 2022, then decreased by 18.3% to 1.01 in 2023, then tumbled by 295.94% to 1.99 in 2024, then soared by 1075.7% to 19.4 in 2025, then sank by 111.86% to 2.3 in 2026.
  • Business Quant data shows CLLS's FCF Payout Ratio at 2.3 in Q1 2026, 19.4 in Q3 2025, and 6.78 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.17
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.07
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Cellectis 306.61 Mn 120.95 Mn - -2.30

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.30
Sep 30, 2025 19.40
Jun 30, 2025 6.78
Mar 31, 2025 -7.61
Sep 30, 2024 -1.99
Jun 30, 2024 0.49
Mar 31, 2024 -5.32
Sep 30, 2023 1.01
Jun 30, 2023 0.06
Mar 31, 2023 -3.04
Sep 30, 2022 1.24
Jun 30, 2022 1.12
Mar 31, 2022 -4.30
Sep 30, 2021 1.45
Jun 30, 2021 -6.11
Mar 31, 2021 -6.34
Sep 30, 2020 -0.01
Jun 30, 2020 3.20
Mar 31, 2020 30.64
Sep 30, 2019 3.17